CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1

PURPOSE: Recent studies indicate that CXC chemokine receptor type 7 (CXCR7) is associated with tumorigenesis, progression, and metastasis of various cancers, but its roles and molecular mechanisms of action in cervical squamous cell carcinoma (CSCC) remain unclear. Our purpose was to explore the exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Danyang, Qin, Wenban, Zhao, Chuanxiang, Long, Jianxiong, Li, Mujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910105/
https://www.ncbi.nlm.nih.gov/pubmed/31849518
http://dx.doi.org/10.2147/CMAR.S228684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910105/
https://www.ncbi.nlm.nih.gov/pubmed/31849518
http://dx.doi.org/10.2147/CMAR.S228684

Ejemplares similares